NO952469D0 - Terapautisk kombinasjon som inneholder interferon - Google Patents
Terapautisk kombinasjon som inneholder interferonInfo
- Publication number
- NO952469D0 NO952469D0 NO952469A NO952469A NO952469D0 NO 952469 D0 NO952469 D0 NO 952469D0 NO 952469 A NO952469 A NO 952469A NO 952469 A NO952469 A NO 952469A NO 952469 D0 NO952469 D0 NO 952469D0
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic combination
- combination containing
- containing interferon
- human interferon
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3417—Details of tips or shafts, e.g. grooves, expandable, bendable; Multiple coaxial sliding cannulas, e.g. for dilating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3476—Powered trocars, e.g. electrosurgical cutting, lasers, powered knives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3494—Trocars; Puncturing needles with safety means for protection against accidental cutting or pricking, e.g. limiting insertion depth, pressure sensors
- A61B17/3496—Protecting sleeves or inner probes; Retractable tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1487—Trocar-like, i.e. devices producing an enlarged transcutaneous opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/32075—Pullback cutting; combined forward and pullback cutting, e.g. with cutters at both sides of the plaque
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
- A61B17/3211—Surgical scalpels, knives; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/34—Trocars; Puncturing needles
- A61B17/3474—Insufflating needles, e.g. Veress needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
- A61B2018/0019—Moving parts vibrating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
- A61M13/003—Blowing gases other than for carrying powders, e.g. for inflating, dilating or rinsing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929226729A GB9226729D0 (en) | 1992-12-22 | 1992-12-22 | Therapeutic combination |
PCT/GB1993/002600 WO1994014473A1 (en) | 1992-12-22 | 1993-12-20 | Therapeutic combination containing interferon |
Publications (2)
Publication Number | Publication Date |
---|---|
NO952469L NO952469L (no) | 1995-06-20 |
NO952469D0 true NO952469D0 (no) | 1995-06-20 |
Family
ID=10727038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952469A NO952469D0 (no) | 1992-12-22 | 1995-06-20 | Terapautisk kombinasjon som inneholder interferon |
Country Status (24)
Country | Link |
---|---|
US (1) | US5830455A (no) |
EP (1) | EP0675730B1 (no) |
JP (2) | JP2849214B2 (no) |
KR (1) | KR100309059B1 (no) |
CN (1) | CN1094642A (no) |
AT (1) | ATE199643T1 (no) |
AU (1) | AU680858B2 (no) |
CA (1) | CA2152389A1 (no) |
DE (1) | DE69330032T2 (no) |
ES (1) | ES2156150T3 (no) |
FR (1) | FR2699407A1 (no) |
GB (1) | GB9226729D0 (no) |
HR (1) | HRP931510A2 (no) |
HU (1) | HUT72965A (no) |
IL (1) | IL108114A (no) |
IT (1) | IT1261949B (no) |
MY (1) | MY141415A (no) |
NO (1) | NO952469D0 (no) |
PL (1) | PL309398A1 (no) |
RU (1) | RU2145235C1 (no) |
TW (1) | TW286283B (no) |
WO (1) | WO1994014473A1 (no) |
YU (1) | YU79393A (no) |
ZA (1) | ZA939583B (no) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508031A (en) * | 1986-11-21 | 1996-04-16 | Cetus Oncology Corporation | Method for treating biological damage using a free-radial scavenger and interleukin-2 |
DE4325547C2 (de) * | 1993-07-29 | 1997-11-27 | Max Planck Gesellschaft | Verwendung von Thiolverbindungen zur Therapie von Hepatitis-_Viren-induzierten Erkrankungen |
US6020205A (en) * | 1998-04-10 | 2000-02-01 | Immunosciences Lab, Inc. | Determination of intracellular antioxidant levels |
RU2156134C2 (ru) * | 1998-05-12 | 2000-09-20 | ООО "Формавит" | Биофармацевтический препарат на основе живой культуры bacillus и способ лечения заболевания инфекционной природы |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
EP1736478B1 (en) | 2000-05-26 | 2015-07-22 | IDENIX Pharmaceuticals, Inc. | Methods and compositions for treating flaviviruses and pestiviruses |
US6878364B2 (en) * | 2000-12-01 | 2005-04-12 | Cornell Research Foundation, Inc. | Animal model for flaviviridae infection |
US6759061B2 (en) * | 2001-08-31 | 2004-07-06 | Renew Life, Inc. | Liver function improvement formulation |
EP1435974A4 (en) * | 2001-09-28 | 2006-09-06 | Idenix Cayman Ltd | METHOD AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUS WITH 4'-MODIFIED NUCLEOSIDES |
US20030158213A1 (en) * | 2001-11-16 | 2003-08-21 | Freeman Bruce A. | Xanthine oxidase inhibition as a strategy to alleviate oxidative impairment of vascular function |
AU2003247084B9 (en) | 2002-06-28 | 2018-07-26 | Centre National De La Recherche Scientifique | Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
BR0312278A (pt) | 2002-06-28 | 2007-06-19 | Idenix Cayman Ltd | éster 2'-c-metil-3'-o-l-valina de ribofuranosil citidina para tratamento de infecções por flaviviridae |
NZ537662A (en) | 2002-06-28 | 2007-10-26 | Idenix Cayman Ltd | 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
JP2004155777A (ja) * | 2002-10-16 | 2004-06-03 | Asahi Kasei Pharma Kk | C型慢性肝炎治療剤 |
RU2005118421A (ru) | 2002-11-15 | 2006-01-20 | Айденикс (Кайман) Лимитед (Ky) | 2'-разветвленные нуклеозиды и мутация flaviviridae |
WO2004050101A2 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
CA2509687C (en) | 2002-12-12 | 2012-08-14 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
EP1626692A4 (en) * | 2003-03-28 | 2008-12-10 | Pharmasset Inc | COMPOUNDS FOR TREATING FLAVIVIRUS INFECTIONS |
PT3521297T (pt) | 2003-05-30 | 2022-03-18 | Gilead Pharmasset Llc | Análogos de nucleosídeo fluorados modificados |
EP1655292B1 (en) * | 2003-07-22 | 2015-04-29 | Kyowa Hakko Bio Co., Ltd | Preventive or therapeutic composition for viral infectious disease |
ES2351603T3 (es) | 2003-07-25 | 2011-02-08 | Idenix Pharmaceuticals, Inc. | Análogos de nucleósidos de purina para el tratamiento de enfermedades causadas por flaviridae incluyendo hepatitis c. |
WO2005018330A1 (en) * | 2003-08-18 | 2005-03-03 | Pharmasset, Inc. | Dosing regimen for flaviviridae therapy |
JP2005104852A (ja) * | 2003-09-29 | 2005-04-21 | Kyowa Hakko Kogyo Co Ltd | モービリウィルス感染症の予防または治療用組成物 |
KR20070011451A (ko) | 2004-05-05 | 2007-01-24 | 예일 유니버시티 | 신규의 항바이러스 헬리오크산틴 유사체 |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
SG192409A1 (en) | 2004-09-14 | 2013-08-30 | Gilead Pharmasset Llc | 2-deoxy-2-fluoro-2-c-methyl-ribono lactones, and preparation thereof and 1,3-dioxolanes |
JP4516863B2 (ja) * | 2005-03-11 | 2010-08-04 | 株式会社ケンウッド | 音声合成装置、音声合成方法及びプログラム |
CU23432B6 (es) | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
US7781576B2 (en) | 2005-12-23 | 2010-08-24 | Idenix Pharmaceuticals, Inc. | Process for preparing a synthetic intermediate for preparation of branched nucleosides |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
AU2009329872B2 (en) | 2008-12-23 | 2016-07-07 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
KR20110098849A (ko) | 2008-12-23 | 2011-09-01 | 파마셋 인코포레이티드 | 뉴클레오시드 유사체 |
AR074897A1 (es) | 2008-12-23 | 2011-02-23 | Pharmasset Inc | Fosforamidatos de nucleosidos |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
TWI576352B (zh) * | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
TW201139457A (en) | 2010-03-31 | 2011-11-16 | Pharmasset Inc | Stereoselective synthesis of phosphorus containing actives |
US10838095B2 (en) | 2010-08-05 | 2020-11-17 | Pgs Geophysical As | Wavefield deghosting of seismic data recorded using multiple seismic sources at different water depths |
CA2818853A1 (en) | 2010-11-30 | 2012-06-07 | Gilead Pharmasset Llc | 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
US8809354B2 (en) | 2011-12-31 | 2014-08-19 | Sheikh Riazuddin | 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
SI3650014T1 (sl) | 2013-08-27 | 2022-01-31 | Gilead Pharmasset Llc | Formulacija kombinacije dveh protivirusnih spojin |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1526205A (en) * | 1974-11-07 | 1978-09-27 | Searle & Co | Treatment of interferon-like material |
US4100150A (en) * | 1975-11-04 | 1978-07-11 | G. D. Searle & Co. | Stabilization of interferon against mechanical stress using thioctic acid |
US4762705A (en) * | 1981-11-10 | 1988-08-09 | Adolf W. Schwimmer | Cancer therapy with interferon |
US4927762A (en) * | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
CH666814A5 (it) * | 1986-07-24 | 1988-08-31 | Inpharzam Int Sa | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. |
US4985241A (en) * | 1986-11-21 | 1991-01-15 | Cetus Corporation | Therapeutic combination of free-radical scavenger and tumor necrosis factor |
CA1321349C (en) * | 1986-11-21 | 1993-08-17 | Robert Zimmerman | Therapeutic combination of free-radical scavenger or metabolic inhibitor and biologically active protein |
IT1231012B (it) * | 1989-07-27 | 1991-11-08 | Zambon Spa | Composizione farmaceutica per uso orale contenente nac. |
US5248697A (en) * | 1990-09-20 | 1993-09-28 | Brigham And Women's Hospital | Enhancement of glutathione levels with glutamine |
EP0486912B1 (de) * | 1990-11-19 | 1996-02-07 | Manz Galvano-Technik GmbH. | Sperr- und Dränagevorrichtung für Tauchtrommeln bei der galvanischen und/oder chemischen Oberflächenbehandlung von Massenteilen |
-
1992
- 1992-12-22 GB GB929226729A patent/GB9226729D0/en active Pending
-
1993
- 1993-04-12 TW TW082102718A patent/TW286283B/zh active
- 1993-12-20 ES ES94902910T patent/ES2156150T3/es not_active Expired - Lifetime
- 1993-12-20 PL PL93309398A patent/PL309398A1/xx unknown
- 1993-12-20 JP JP6514930A patent/JP2849214B2/ja not_active Expired - Lifetime
- 1993-12-20 CA CA002152389A patent/CA2152389A1/en not_active Abandoned
- 1993-12-20 YU YU79393A patent/YU79393A/sh unknown
- 1993-12-20 WO PCT/GB1993/002600 patent/WO1994014473A1/en active IP Right Grant
- 1993-12-20 DE DE69330032T patent/DE69330032T2/de not_active Expired - Fee Related
- 1993-12-20 KR KR1019950702659A patent/KR100309059B1/ko not_active IP Right Cessation
- 1993-12-20 HU HU9501841A patent/HUT72965A/hu unknown
- 1993-12-20 EP EP94902910A patent/EP0675730B1/en not_active Expired - Lifetime
- 1993-12-20 RU RU95113492A patent/RU2145235C1/ru active
- 1993-12-20 AT AT94902910T patent/ATE199643T1/de not_active IP Right Cessation
- 1993-12-20 AU AU57076/94A patent/AU680858B2/en not_active Ceased
- 1993-12-21 IL IL10811493A patent/IL108114A/en active IP Right Grant
- 1993-12-21 FR FR9315349A patent/FR2699407A1/fr active Pending
- 1993-12-21 JP JP5322685A patent/JPH06234657A/ja active Pending
- 1993-12-21 HR HR931510A patent/HRP931510A2/hr not_active Application Discontinuation
- 1993-12-21 ZA ZA939583A patent/ZA939583B/xx unknown
- 1993-12-21 MY MYPI93002794A patent/MY141415A/en unknown
- 1993-12-21 CN CN93121281A patent/CN1094642A/zh active Pending
- 1993-12-21 IT ITRM930840A patent/IT1261949B/it active IP Right Grant
-
1995
- 1995-06-20 NO NO952469A patent/NO952469D0/no not_active Application Discontinuation
-
1996
- 1996-09-06 US US08/706,645 patent/US5830455A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU680858B2 (en) | 1997-08-14 |
NO952469L (no) | 1995-06-20 |
PL309398A1 (en) | 1995-10-02 |
ES2156150T3 (es) | 2001-06-16 |
AU5707694A (en) | 1994-07-19 |
ATE199643T1 (de) | 2001-03-15 |
DE69330032D1 (de) | 2001-04-19 |
HU9501841D0 (en) | 1995-08-28 |
IT1261949B (it) | 1996-06-04 |
IL108114A (en) | 1999-12-31 |
TW286283B (no) | 1996-09-21 |
ITRM930840A0 (it) | 1993-12-21 |
US5830455A (en) | 1998-11-03 |
KR100309059B1 (ko) | 2002-06-20 |
RU2145235C1 (ru) | 2000-02-10 |
HUT72965A (en) | 1996-06-28 |
EP0675730A1 (en) | 1995-10-11 |
CN1094642A (zh) | 1994-11-09 |
JPH06234657A (ja) | 1994-08-23 |
GB9226729D0 (en) | 1993-02-17 |
ITRM930840A1 (it) | 1995-06-21 |
EP0675730B1 (en) | 2001-03-14 |
ZA939583B (en) | 1995-05-22 |
FR2699407A1 (fr) | 1994-06-24 |
WO1994014473A1 (en) | 1994-07-07 |
JPH08504799A (ja) | 1996-05-21 |
HRP931510A2 (en) | 1995-12-31 |
IL108114A0 (en) | 1994-04-12 |
MY141415A (en) | 2010-04-30 |
YU79393A (sh) | 1996-10-09 |
DE69330032T2 (de) | 2001-09-06 |
JP2849214B2 (ja) | 1999-01-20 |
CA2152389A1 (en) | 1994-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO952469D0 (no) | Terapautisk kombinasjon som inneholder interferon | |
BG60253B1 (bg) | Човешки тъканен плазминогенен активатор | |
DE69320485D1 (de) | VERWENDUNG VON MELATONIN in niedrigen oralen Dosen ZUM HERBEIFÜHREN VON SCHLAF | |
DK0713701T3 (da) | 2-Brommelatonin til behandling af søvnforstyrrelser | |
RO115700B1 (ro) | Metodă de tratament cu interferon | |
EP0244080A3 (en) | Medicament for the treatment of obesity | |
NO20032027L (no) | Effektive antitumorbehandlinger | |
SE9701161D0 (sv) | New use I | |
DK0637306T3 (da) | 4-Imidomethyl-1-[2'-phenyl-2'-oxoethyl]-piperidiner som serotonin-5HT2-antagonister, deres fremstilling og anvendelse til terapi | |
ES2063060T3 (es) | Benzamida contra enfermedades cognoscitivas. | |
ES2087765T3 (es) | Uso del ajo silvestre para la terapia o profilaxis de trastornos del ritmo cardiaco. | |
DE69623316D1 (de) | Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen | |
ATE149840T1 (de) | Behandlung von leberkrebs | |
GR3019819T3 (en) | Use of wild garlic for the therapy or prevention of blood circulation disturbances. | |
NZ332690A (en) | Stimulation of host defence mechanisms against viral challenges using interferon | |
NO953003L (no) | Anvendelse av ifenprodil og diastereoisomerer derav for fremstilling av medisinske preparater | |
EP0804204A4 (en) | TREATMENT OF DISEASES RELATED TO FREE RADICAL EDUCATION | |
NO995539L (no) | Anvendelse av hepariner med lav molekylvekt for prevensjon og terapi av cerebrale ödemer | |
DK0673646T3 (da) | Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme | |
DE69109933D1 (de) | Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose. | |
ITFI920241A0 (it) | Impiego della melatonina nella terapia della sclerosi sistematica, della sarcoidosi ed altro | |
ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
IT8322369A0 (it) | Applicazione terapeutica delmazindolo nel trattamento delrussamento. | |
DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
UA7948A (uk) | Пристрій для сочетаної вакуум-лазерної терапії |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |